Published in Ann Surg Oncol on October 15, 2004
Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol (2008) 2.77
Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol (2008) 1.60
Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. J Clin Oncol (2010) 1.54
Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health Qual Life Outcomes (2010) 0.97
A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection. Ann Surg Oncol (2010) 0.93
Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol (2008) 0.92
A systematic review of the effect of low-level laser therapy in the management of breast cancer-related lymphedema. Support Care Cancer (2012) 0.91
Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer--a prospective study. World J Surg Oncol (2011) 0.89
Prediction of treatment outcome with bioimpedance measurements in breast cancer related lymphedema patients. Ann Rehabil Med (2011) 0.86
Patient-reported upper extremity outcome measures used in breast cancer survivors: a systematic review. Arch Phys Med Rehabil (2013) 0.86
A qualitative assessment of upper quarter dysfunction reported by physical therapists treated for breast cancer or treating breast cancer sequelae. Support Care Cancer (2010) 0.81
Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer. Int Semin Surg Oncol (2005) 0.80
Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: a review of the literature. World J Surg Oncol (2005) 0.80
Predictors of Altered Upper Extremity Function During the First Year After Breast Cancer Treatment. Am J Phys Med Rehabil (2016) 0.78
Physiotherapeutic stimulation: Early prevention of lymphedema following axillary lymph node dissection for breast cancer treatment. Exp Ther Med (2010) 0.77
Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32. J Support Oncol (2013) 0.75
Shoulder impairment before breast cancer surgery. J Womens Health Phys Therap (2014) 0.75
Validity of Quantitative Lymphoscintigraphy as a Lymphedema Assessment Tool for Patients With Breast Cancer. Ann Rehabil Med (2015) 0.75
Efficacy of Sentinel Lymph Node Biopsy in Detecting Axillary Metastasis in Breast Cancer Using Methylene Blue. Indian J Surg Oncol (2016) 0.75
Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science (1990) 3.70
Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. J Immunol (1988) 3.65
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol (1996) 2.61
Biological properties of interleukin 10. J Clin Immunol (1992) 2.50
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J (2009) 2.21
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med (2000) 2.19
[Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]. Ned Tijdschr Geneeskd (2008) 2.06
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol (2007) 1.98
Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients. J Clin Oncol (2001) 1.92
Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol (1995) 1.90
Campylobacter jejuni non-culturable coccoid cells. Int J Food Microbiol (1992) 1.89
The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88
Molecular biology of interleukin 4 and interleukin 5 genes and biology of their products that stimulate B cells, T cells and hemopoietic cells. Immunol Rev (1988) 1.84
Phantom pain and phantom sensations in upper limb amputees: an epidemiological study. Pain (2000) 1.81
Assessing the privacy risks of data sharing in genomics. Public Health Genomics (2010) 1.78
Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J (2010) 1.74
Extensibility and stiffness of the hamstrings in patients with nonspecific low back pain. Arch Phys Med Rehabil (2001) 1.73
Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010. Ann Oncol (2011) 1.73
EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer. Ann Oncol (2006) 1.72
Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol (2012) 1.70
Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother Oncol (1998) 1.65
Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. Diabet Med (2002) 1.65
Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J (1999) 1.62
Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol (2000) 1.62
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev (2004) 1.60
Severe anaphylactic shock after rechallenge with abacavir without preceding hypersensitivity. AIDS (2001) 1.59
Quantitative analysis of traction in the glenohumeral joint. In vivo radiographic measurements. Man Ther (2003) 1.55
Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results. Chest (2001) 1.55
Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol (2002) 1.54
Thoracoscopic ligation of a thoracic duct leakage. Chest (1994) 1.54
Comparison between isotropic and nonisotropic dosimetry systems during intraperitoneal photodynamic therapy. Lasers Surg Med (2000) 1.54
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.52
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group. Eur J Cancer (1997) 1.52
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study. Ann Oncol (2004) 1.52
Measurement by nerve fiber analyzer of retinal nerve fiber layer thickness in normal subjects and patients with ocular hypertension. Am J Ophthalmol (1996) 1.52
Concordance of phenprocoumon dosage in married couples. BMJ (1997) 1.51
Socio-economic differences in health risk behavior in adolescence: do they exist? Soc Sci Med (1998) 1.50
Mechanism of action of antitumor drug etoposide: a review. J Natl Cancer Inst (1988) 1.50
Quality of life and health status before and after ileal pouch-anal anastomosis for ulcerative colitis. Br J Surg (2011) 1.49
Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment. Clin Endocrinol (Oxf) (1998) 1.49
Continuous leakage measurement during hyperthermic isolated limb perfusion. Ann Surg Oncol (2001) 1.49
Trends in return to work of breast cancer survivors. Breast Cancer Res Treat (2011) 1.48
Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (1998) 1.47
Skin protection in nursing work: promoting the use of gloves and hand alcohol. Contact Dermatitis (2004) 1.45
Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors. Lab Invest (1994) 1.44
Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity. Clin Cancer Res (2000) 1.42
Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol (2003) 1.41
[Incidence and prevalence of genetically-determined disorders in The Netherlands; a literature study]. Ned Tijdschr Geneeskd (1994) 1.41
Predicting postoperative mortality after colorectal surgery: a novel clinical model. Colorectal Dis (2014) 1.41
Rigorous management of sickness absence provokes sickness presenteeism. Occup Med (Lond) (2010) 1.40
[The role of health care in occupationally disability]. Ned Tijdschr Geneeskd (1996) 1.40
Evaluation of quality of life in sarcoidosis patients. Respir Med (1998) 1.40
Uncertainty in decision models analyzing cost-effectiveness: the joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method. Med Decis Making (1998) 1.39
[Pleurodesis in malignant pleural effusion]. Ned Tijdschr Geneeskd (1997) 1.39
Shoulder fusion for paralyzed upper limb. Clin Orthop Relat Res (1997) 1.39
[Myositis as the first manifestation of an exacerbation of Crohn's disease]. Ned Tijdschr Geneeskd (2007) 1.39
[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. Ned Tijdschr Geneeskd (2005) 1.39
Quantitative assessment of calf circumference in Duchenne muscular dystrophy patients. Neuromuscul Disord (2002) 1.38
Prognostic factors of long term disability due to mental disorders: a systematic review. J Occup Rehabil (2011) 1.38
Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg (1992) 1.38
Prosthetic prescription in the Netherlands: an interview with clinical experts. Prosthet Orthot Int (2004) 1.38
Isolation and characterization of an expressible cDNA encoding human IL-3. Induction of IL-3 mRNA in human T cell clones. J Immunol (1988) 1.36
Self-expanding and balloon-expandable stents in the treatment of carotid aneurysms: an experimental study in a canine model. AJNR Am J Neuroradiol (1994) 1.36
The current status of S-100B as a biomarker in melanoma. Eur J Surg Oncol (2012) 1.34
Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol (2006) 1.33
Percutaneous vertebroplasty and pulmonary cement embolism: results from VERTOS II. AJNR Am J Neuroradiol (2010) 1.33
Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol (1993) 1.29
Hydrophobic and electrostatic cell surface properties of thermophilic dairy streptococci. Appl Environ Microbiol (1993) 1.29
Genetic predisposition to testicular germ-cell tumours. Lancet Oncol (2004) 1.28
Epiphyseal fractures in children treated for osteosarcoma of the femur with chemotherapy, tumourresection, and endoprosthesis: report of four fractures in two children. J Surg Oncol (1984) 1.28
Aqueous humor analysis as a diagnostic tool in toxoplasma uveitis. Int Ophthalmol (1989) 1.27
Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors. Ann Oncol (2009) 1.25
The predictive value of serum angiotensin converting enzyme and lysozyme levels in the diagnosis of ocular sarcoidosis. Am J Ophthalmol (1987) 1.24
Limb salvage surgery for primary bone sarcoma of the lower extremities: long-term consequences of endoprosthetic reconstructions. Ann Surg Oncol (1998) 1.24
Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.23
Anisometropia in children: analysis of a hospital population. Br J Ophthalmol (1985) 1.22
Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22
Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol (2006) 1.21
The cytoskeleton of neurites after microtubule depolymerization. Exp Cell Res (1986) 1.21
Frequent and long-term absence as a risk factor for work disability and job termination among employees in the private sector. Occup Environ Med (2007) 1.20
Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients. Br J Clin Pharmacol (2006) 1.20
Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma. Ann Surg Oncol (2003) 1.19
The Timed "up and go" test: reliability and validity in persons with unilateral lower limb amputation. Arch Phys Med Rehabil (1999) 1.18